Matsuda, Y., Narita, S., Nara, T., Mingguo, H., Sato, H., Koizumi, A., . . . Habuchi, T. (2020). Impact of nuclear YAP1 expression in residual cancer after neoadjuvant chemohormonal therapy with docetaxel for high-risk localized prostate cancer. BMC Cancer.
Stile di citazione ChicagoMatsuda, Yoshinori, et al. "Impact of Nuclear YAP1 Expression in Residual Cancer After Neoadjuvant Chemohormonal Therapy With Docetaxel for High-risk Localized Prostate Cancer." BMC Cancer 2020.
Citazione MLAMatsuda, Yoshinori, et al. "Impact of Nuclear YAP1 Expression in Residual Cancer After Neoadjuvant Chemohormonal Therapy With Docetaxel for High-risk Localized Prostate Cancer." BMC Cancer 2020.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.